» Articles » PMID: 38231214

Clinical Pathogenesis, Molecular Mechanisms of Gastric Cancer Development

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

The human pathogen Helicobacter pylori is the strongest known risk factor for gastric disease and cancer, and gastric cancer remains a leading cause of cancer-related death across the globe. Carcinogenic mechanisms associated with H. pylori are multifactorial and are driven by bacterial virulence constituents, host immune responses, environmental factors such as iron and salt, and the microbiota. Infection with strains that harbor the cytotoxin-associated genes (cag) pathogenicity island, which encodes a type IV secretion system (T4SS) confer increased risk for developing more severe gastric diseases. Other important H. pylori virulence factors that augment disease progression include vacuolating cytotoxin A (VacA), specifically type s1m1 vacA alleles, serine protease HtrA, and the outer-membrane adhesins HopQ, BabA, SabA and OipA. Additional risk factors for gastric cancer include dietary factors such as diets that are high in salt or low in iron, H. pylori-induced perturbations of the gastric microbiome, host genetic polymorphisms, and infection with Epstein-Barr virus. This chapter discusses in detail host factors and how H. pylori virulence factors augment the risk of developing gastric cancer in human patients as well as how the Mongolian gerbil model has been used to define mechanisms of H. pylori-induced inflammation and cancer.

Citing Articles

Cultivation and molecular characterization of viable Helicobacter pylori from the root canal of 170 deciduous teeth of children.

Elger W, Tegtmeyer N, Rohde M, Linz B, Hirsch C, Backert S Cell Commun Signal. 2024; 22(1):578.

PMID: 39627817 PMC: 11613870. DOI: 10.1186/s12964-024-01948-5.


GRB7-mediated enhancement of cell malignant characteristics induced by infection.

Zhao H, Chen S, Bai X, Zhang J, Liu S, Sun Z Front Microbiol. 2024; 15:1469953.

PMID: 39360313 PMC: 11444978. DOI: 10.3389/fmicb.2024.1469953.

References
1.
Ivie S, McClain M, Torres V, Algood H, Lacy D, Yang R . Helicobacter pylori VacA subdomain required for intracellular toxin activity and assembly of functional oligomeric complexes. Infect Immun. 2008; 76(7):2843-51. PMC: 2446698. DOI: 10.1128/IAI.01664-07. View

2.
Caso G, McClain M, Erwin A, Truelock M, Campbell A, Leasure C . Functional Properties of Oligomeric and Monomeric Forms of Helicobacter pylori VacA Toxin. Infect Immun. 2021; 89(12):e0034821. PMC: 8594603. DOI: 10.1128/IAI.00348-21. View

3.
El-Omar E, Carrington M, Chow W, McColl K, Bream J, Young H . The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature. 2002; 412(6842):99. DOI: 10.1038/35083631. View

4.
Ndegwa N, Ploner A, Andersson A, Zagai U, Andreasson A, Vieth M . Gastric Microbiota in a Low-Helicobacter pylori Prevalence General Population and Their Associations With Gastric Lesions. Clin Transl Gastroenterol. 2020; 11(7):e00191. PMC: 7431247. DOI: 10.14309/ctg.0000000000000191. View

5.
Shibata W, Hirata Y, Maeda S, Ogura K, Ohmae T, Yanai A . CagA protein secreted by the intact type IV secretion system leads to gastric epithelial inflammation in the Mongolian gerbil model. J Pathol. 2006; 210(3):306-14. DOI: 10.1002/path.2040. View